EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is There a “Non-Motor Effect” of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms?

Małgorzata Dudzic iD, Anna Pieczyńska iD, Artur Drużdż, Anna Rajewska, Katarzyna Hojan iD

Toxins · 2025

DOI: 10.3390/toxins17080396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Małgorzata Dudzic und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Joseph Strus Municipal Hospital in Poznan, 61-285 Poznan, Poland. Hauptthemen laut MEDLINE: Torticollis, Botulinum Toxins, Type A, Neuromuscular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of botulinum toxin A (BoNT) in alleviating motor symptoms of cervical dystonia (CD) has been well established, and it is the treatment of choice in this disease. Lately, the effect of BoNT on non-motor symptoms (NMS) such as cognitive function, depression, anxiety, pain, and sleep disturbance has been observed in patients with CD. A comprehensive clinical and functional assessment of motor (dystonia severity, gait) and non-motor symptoms (cognitive functions, depression, anxiety, sleep, and pain) has been performed in a total of 34 adult patients with cervical dystonia before and after BoNT treatment. Results have also been compared to a control group. Significant improvements in the scales assessing dystonia severity have been observed, which is in line with previous studies on the effect of BoNT on motor symptoms in dystonia. Interestingly, the results also clearly indicate that BoNT has a positive effect on NMS. Among the studied non-motor domains, depression and cognitive functions improved the most after the treatment procedure. The study highlights the potential of BoNT to positively influence non-motor symptoms in patients with cervical dystonia, although its effect on various NMS is not equal.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TorticollisBotulinum Toxins, Type ANeuromuscular AgentsHumansMaleFemaleMiddle AgedCognitionDepressionTreatment OutcomeAdultAgedAnxiety

Stichwörter der Autor:innen

anxietybotulinum toxin type Acervical dystoniacognitive impairmentdepressionnon-motor symptomsoptimization of resultssleep disturbancessocial anxiety

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Department of Neurology, Joseph Strus Municipal Hospital in Poznan, 61-285 Poznan, Poland.
  • Department of Occupational Therapy, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
  • Department of Rehabilitation, Greater Poland Cancer Centre, 61-866 Poznan, Poland.
  • Neurorehabilitation Ward, Greater Poland Provincial Hospital, 60-479 Poznan, Poland.

ORCID-Profile: Małgorzata Dudzic, Anna Pieczyńska, Katarzyna Hojan

Zitieren

APA

Dudzic, M., Pieczyńska, A., Drużdż, A., Rajewska, A., & Hojan, K. (2025). Is There a “Non-Motor Effect” of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms?. Toxins. https://doi.org/10.3390/toxins17080396

Vancouver

Dudzic M, Pieczyńska A, Drużdż A, Rajewska A, Hojan K. Is There a “Non-Motor Effect” of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms?. Toxins. 2025. doi:10.3390/toxins17080396

BibTeX
@article{Dudzic2025,
  author = {Dudzic, Małgorzata and Pieczyńska, Anna and Drużdż, Artur and Rajewska, Anna and Hojan, Katarzyna},
  title = {Is There a “Non-Motor Effect” of Botulinum Toxin Treatment in Cervical Dystonia in Addition to Its Effects on Motor Symptoms?},
  journal = {Toxins},
  year = {2025},
  doi = {10.3390/toxins17080396}
}
Kostenlos starten →